CoreCap Advisors, LLC

Position in NVS — Novartis AG

CIK 1902501 SOUTHFIELD, MI

Position in NVS

as of Jun 30, 2026 · filed Jul 6, 2026 Compact

Position Value

$418,599

+$174,658 QoQ

Shares Held

2,671

+67.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#970

of 1,603 holders

Holding Since

Dec 2021

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

CoreCap Advisors, LLC holds $42,526,097 across 17 Drug Manufacturers - General names. NVS ranks #9 (1.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	47,921	$12,170,496
2	MRK	Merck & Co., Inc.	61,485	$7,900,822
3	GILD	Gilead Sciences, Inc.	46,624	$5,890,476
4	ABBV	AbbVie Inc.	20,967	$5,276,135
5	LLY	ELI LILLY & Co	3,816	$4,577,025
6	AMGN	Amgen Inc	5,755	$2,084,000
7	PFE	Pfizer Inc	85,905	$2,068,592
8	BMY	Bristol Myers Squibb Co	24,801	$1,429,033

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$418,599	2,671	+67.3%	Shares	Sole	2026-07-06
2026-03-31	$243,941	1,597	+2.6%	Shares	Sole	2026-04-07
2025-12-31	$214,525	1,556	+10.8%	Shares	Sole	2026-01-13
2025-09-30	$180,048	1,404	-23.1%	Shares	Sole	2025-10-22
2025-06-30	$220,843	1,825	+35.2%	Shares	Sole	2025-08-14
2025-03-31	$150,498	1,350	-35.1%	Shares	Sole	2025-05-09
2024-12-31	$202,307	2,079	+33.6%	Shares	Sole	2025-02-14
2024-09-30	$178,971	1,556	+294.9%	Shares	Sole	2024-11-08
2024-06-30	$41,945	394	+6.5%	Shares	Sole	2024-08-08
2024-03-31	$35,790	370	-8.9%	Shares	Sole	2024-08-08
2022-12-31	$36,832	406	-73.0%	Shares	Sole	2023-02-10
2022-06-30	$126,964	1,502	-26.3%	Shares	Sole	2022-08-11
2021-12-31	$178,263	2,038	—	Shares	Sole	2022-02-10
No filing history on record for this holder in this stock.